Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis

Published:2023-01 Issue:1 Volume:9 Page:96-105
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Mandel Philipp,Hoeh Benedikt,Wenzel Mike,Preisser Felix,Tian Zhe,Tilki Derya,Steuber Thomas,Karakiewicz Pierre I.,Chun Felix K.H.

Publisher

Elsevier BV

Reference30 articles.

1. Mottet N, Cornford P, Briers E, et al. EAU prostate cancer guidelines. Presented at the EAU Annual Congress Amsterdam 2022. Arnhem, the Netherlands: EAU Guidelines Office. https://uroweb.org/guidelines/prostate-cancer.

2. Metastatic hormone-sensitive prostate cancer: a review of the current treatment landscape;Kinsey;Cancer J,2020

3. Contemporary role of androgen deprivation therapy for prostate cancer;Pagliarulo;Eur Urol,2012

4. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

5. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial;Kyriakopoulos;J Clin Oncol,2018

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do Older Patients With Metastatic Hormone-Sensitive Prostate Cancer Benefit From Triplet or Doublet Therapy? A Network Meta-Analysis;Clinical Genitourinary Cancer;2025-08

2. Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer;European Urology Open Science;2025-07

3. Packing the Punch: Current and Emerging Treatment Strategies in Metastatic Castration-Sensitive Prostate Cancer;Current Urology Reports;2025-06-21

4. Transforming Prostate Cancer Care: Innovations in Diagnosis, Treatment, and Future Directions;International Journal of Molecular Sciences;2025-06-04

5. Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2025-06